Skip to content

Satisfaction of Hospitalized Diabetic Patients Using a Continuous Glucose Monitoring System

Satisfaction of Using a Continuous Glucose Monitoring System to Monitor Interstitial Fluid Glucose Level in Hospitalized Insulin-dependent Diabetic Patients Treated Using a Portable Sub-cutaneous Pump

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03411460
Acronym
GLUCO FLASH
Enrollment
10
Registered
2018-01-26
Start date
2017-04-19
Completion date
2017-08-23
Last updated
2018-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin-Dependent Diabetes

Brief summary

The aim of the study is to establish whether routine usage of the FreeStyle Libre™ system (Abbott) improves satisfaction and quality of sleep in patients hospitalized for poor glycemic control with an indication for external insulin pump treatment.

Interventions

DEVICEFreeStyle Libre™ system

Measured non-invasively via scanner

PROCEDUREFinger prick

Blood test

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patient has given their free and informed consent * The patient must be insured or the beneficiary of an insurance policy * The patient is aged at least 18 years and less than 75 years old. * Patients have a BMI between 18 and 40kg/m2 * Diabetic patient admitted for glycemic instability with indication for treatment using an external insulin pump but otherwise in a stable clinical state

Exclusion criteria

* The subject is participating in another study * The subject is in an exclusion period determined by a previous study * The patients is under judicial protection or state guardianship * The subject refuses to sign the consent form * It proves impossible to give the subject clear information. * The patient is pregnant, parturient or breastfeeding * The patient is clinically unstable * BMI less than 18 or over 40 * Existence of a severe rapidly progressive ischemic retinopathy or proliferative retinopathy. * Serious psychiatric problems * Chronic cutaneous infection

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction of patient-determined hospital care at discharge in the two groupsat discharge from hospital; maximum Day 5visual analogue scale 0-10

Secondary

MeasureTime frameDescription
Patient quality of sleepat each day of hospitalization and discharge; maximum Day 5Spiegel questionnaire
Satisfaction of nursing staff concerning care of patientat end of study; maximum Day 5visual analogue scale response to 5 quesions
Time taken by nurse to measure circulating glucose levelDaily over length of hospitalization until maximum Day 5in minutes
Patient satisfaction concerning treatment for their diabetesat discharge from hospital; maximum Day 5Diabetes Treatment Satisfaction Questionnaire
Number of glucose readings above 2g/l and below 0.80g/l over the hospital staymaximum Day 5
Number of hypoglycmic events with the corresponding glucose levelmaximum Day 5
Time necessary to achieve satisfactory equilibrium using insulin pumpmaximum Day 5average daily glucose level \< 1.50 g/l

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026